Pioneering Biotech rapidly scales up supply chain with Almac to join global fight against COVID-19
The onset of the global COVID-19 pandemic catapulted drug development into the international spotlight. For one biotech sponsor, successfully scaling-up its supply chain to accommodate the unprecedented demand of operating global COVID-19 studies, while ensuring cost-effective continuity of supply to patients enrolled in current and planned oncology trials, was mission critical.
Download our case study to follow the journey of one biotech sponsor who elevated their existing relationship with Almac Clinical Services to accommodate a rapid scale up of their COVID-19 trial, while continuing to deliver patient-centric supply for their ongoing core business studies on time and on budget.
To learn more about how Almac Clinical Services can support and scale your innovative trial, click here.View Resource
Almac Clinical Services
Guided by our extensive clinical supply experience and expertise, Almac Clinical Services is recognised as an innovative, global solution provider within the specialised and complex market of clinical trial supply.
Our integrated and adaptable solutions offer the most flexible approach to support the delivery of global clinical trials from protocol right through to patient delivery.
Our core purpose is to be the partner of choice, to deliver the next generation of health care solutions effectively and to focus on winning for you and your patients.